Plasma tissue kallikrein level is negatively associated with incident and recurrent stroke: A multicenter case–control study in China

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of Neurology

• Publication date

  2011-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ana.22404PMID 21823154
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased tissue kallikrein levels in type 2 diabetes

  2010cited by this paper
• Tissue kallikrein protects cortical neurons against in vitro ischemia-acidosis/reperfusion-induced injury through the ERK1/2 pathway.

  2009cited by this paper
• Tissue kallikrein alleviates glutamate‐induced neurotoxicity by activating ERK1

  2009cited by this paper
• Tissue kallikrein deficiency aggravates cardiac remodelling and decreases survival after myocardial infarction in mice

  2008cited by this paper
• Protease‐activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines

  2008cited by this paper
• Delivery of Recombinant Adeno-Associated Virus-Mediated Human Tissue Kallikrein for Therapy of Chronic Renal Failure in Rats

  2008cited by this paper
• Exogenous kallikrein enhances neurogenesis and angiogenesis in the subventricular zone and the peri-infarction region and improves neurological function after focal cortical infarction in hypertensive rats.

  2008cited by this paper
• Tissue Kallikrein Elicits Cardioprotection by Direct Kinin B2 Receptor Activation Independent of Kinin Formation

  2008cited by this paper
• Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5'-monophosphate-activated protein kinase signaling pathways.

  2007cited by this paper
• Alcohol consumption and risk for stroke among Chinese men

  2007cited by this paper
• Intramuscular delivery of rAAV-mediated kallikrein gene reduces hypertension and prevents cardiovascular injuries in model rats

  2007cited by this paper
• The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction

  2006cited by this paper
• Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction.

  2006cited by this paper
• VKORC1 Haplotypes Are Associated With Arterial Vascular Diseases (Stroke, Coronary Heart Disease, and Aortic Dissection)

  2006cited by this paper
• Kallikrein Protects Against Ischemic Stroke by Inhibiting Apoptosis and Inflammation and Promoting Angiogenesis and Neurogenesis

  2006cited by this paper
• Kallikrein–kinin in stroke, cardiovascular and renal disease

  2005cited by this paper
• The kallikrein-kinin system: current and future pharmacological targets.

  2005cited by this paper
• Release of Bradykinin and Expression of Kinin B2 Receptors in the Brain: Role for Cell Death and Brain Edema Formation After Focal Cerebral Ischemia in Mice

  2005cited by this paper
• Kallikrein Gene Transfer Protects Against Ischemic Stroke by Promoting Glial Cell Migration and Inhibiting Apoptosis

  2004cited by this paper
• Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries

  2004cited by this paper
• Natriuretic Peptide Receptor-C Regulates Coronary Blood Flow and Prevents Myocardial Ischemia/Reperfusion Injury: Novel Cardioprotective Role for Endothelium-Derived C-Type Natriuretic Peptide

  2004cited by this paper
• Gene Therapy With Human Tissue Kallikrein Reduces Hypertension and Hyperinsulinemia in Fructose-Induced Hypertensive Rats

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Arachidonic acid as a bioactive molecule.

  2001cited by this paper
• Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study.

  2001cited by this paper
• Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases.

  2000cited by this paper
• Adenovirus-mediated human tissue kallikrein gene delivery inhibits neointima formation induced by interruption of blood flow in mice.

  2000cited by this paper
• Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats.

  1999cited by this paper
• Kallikrein gene delivery inhibits vascular smooth muscle cell growth and neointima formation in the rat artery after balloon angioplasty.

  1999cited by this paper
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

  1997cited by this paper
• Nitric oxide synthase in models of focal ischemia.

  1997cited by this paper
• The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (NIH Publication No. 98-4080)

  1997cited by this paper
• The paradox of high risk of stroke in populations with low risk of coronary heart disease.

  1990cited by this paper
• Kinin Receptor Subtypes

  1990cited by this paper
• A gene for high urinary kallikrein may protect against hypertension in Utah kindreds.

  1989cited by this paper
• Stability of Blood Pressure Rank and Urinary Kallikrein Concentration in Childhood: An Eight-Year Follow-Up

  1978cited by this paper
• The International Classification of Diseases: ninth revision (ICD-9)

  1978influential reference
• Urinary Kallikrein in Normal Renin Essential Hypertension

  1977cited by this paper

• Prognostic value of TC/HDL-C ratios in ischemic stroke: a multicenter observational study

  2026cites this paper
• Pharmacological characterization and neuroprotective efficacy of ZHB103, a novel long-acting rhKLK1.

  2026cites this paper
• Tissue Kallikrein as a Mediator in Stroke Outcomes among Patients With Metabolic Syndrome: A Multicenter Study Integrating Big Data and Biomarkers

  2025influential citation
• Integrating endothelium-derived hyperpolarization, nitric oxide, and prostacyclin pathways: the multimodal potential of human tissue kallikrein-1

  2025cites this paper
• Safety and Tolerability of Rinvecalinase Alfa (DM199) for Acute Ischemic Stroke (ReMEDy1).

  2025cites this paper
• Integrating Endothelial-Derived Hyperpolarizing Signaling into a Multitarget Therapeutic Strategy for Microvascular Disease

  2025cites this paper
• Recombinant Human Tissue Kallikrein-1 for Treating Acute Ischemic Stroke and Preventing Recurrence

  2025cites this paper
• IL-6 and stroke recurrence in ischemic stroke.

  2024cites this paper
• Imbalance Between Angiotensin II and Kallikrein in Patients With ST-Segment Elevation Myocardial Infarction: A Case-Control Emergency Room Study

  2024cites this paper
• Ulinastatin attenuated cardiac ischaemia/reperfusion injury by suppressing activation of the tissue kallikrein‐kinin system

  2024cites this paper
• Tissue Kallikrein Supplementation in Ischemic Phase Protects the Neurovascular Unit and Attenuates Reperfusion-Induced Injury in Ischemic Stroke.

  2024cites this paper
• The effectiveness and safety of human urinary kallidinogenase in acute ischemic stroke patients undergoing endovascular therapy

  2024influential citation
• Dyslipidemia versus obesity as predictors of ischemic stroke prognosis: a multi-center study in China

  2024cites this paper
• Decreased Tissue Kallikrein Levels and the Risk of Ischemic Stroke: A Community-Based Cross-Sectional Study in China

  2022cites this paper
• Tissue Kallikrein Exacerbating Sepsis-Induced Endothelial Hyperpermeability is Highly Predictive of Severity and Mortality in Sepsis

  2021cites this paper
• Serum Interleukin-37 Increases in Patients after Ischemic Stroke and Is Associated with Stroke Recurrence

  2021cites this paper
• Increase in Blood–Brain Barrier Permeability is Modulated by Tissue Kallikrein via Activation of Bradykinin B1 and B2 Receptor-Mediated Signaling

  2021cites this paper
• Association between serum 25-hydroxyvitamin d and early recurrent ischemic stroke

  2020cites this paper
• Tissue kallikrein: a potential serum biomarker to predict delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage.

  2019cites this paper
• Serum fatty acid binding protein 4 is positively associated with early stroke recurrence in nondiabetic ischemic stroke

  2019cites this paper
• High Level of Serum Tissue Kallikrein Is Associated with Favorable Outcome in Acute Ischemic Stroke Patients

  2019cites this paper
• Determination of serum tissue kallikrein levels after traumatic brain injury.

  2019cites this paper
• Therapeutic Values of Human Urinary Kallidinogenase on Cerebrovascular Diseases

  2018cites this paper
• Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.

  2018cites this paper
• Macrophage Migration Inhibitory Factor Levels Correlate with Stroke Recurrence in Patients with Ischemic Stroke

  2018cites this paper
• Serum Copeptin Predicts Severity and Recurrent Stroke in Ischemic Stroke Patients

  2017cites this paper
• Human urine kininogenase attenuates balloon-induced intimal hyperplasia in rabbit carotid artery through transforming growth factor β1/Smad2/3 signaling pathway.

  2016cites this paper
• Vitamin D status and the risk of recurrent stroke and mortality in ischemic stroke patients: Data from a 24-month follow-up study in China

  2016cites this paper
• Tissue Kallikrein Prevents Restenosis After Stenting of Severe Atherosclerotic Stenosis of the Middle Cerebral Artery

  2016cites this paper
• Serum 25-hydroxyvitamin D predicts early recurrent stroke in ischemic stroke patients.

  2016cites this paper
• Lipoprotein (a) as a Predictor of Early Stroke Recurrence in Acute Ischemic Stroke

  2016cites this paper
• Tissue Kallikrein Activity, Detected by a Novel Method, May Be a Predictor of Recurrent Stroke: A Case-Control Study

  2015cites this paper
• Human Urinary Kallidinogenase Improves Outcome of Stroke Patients by Shortening Mean Transit Time of Perfusion Magnetic Resonance Imaging.

  2015cites this paper
• Relation of Plasma Tissue Kallikrein Levels to Presence and Severity of Coronary Artery Disease in a Chinese Population

  2014cites this paper
• Identification of Circulating MicroRNAs as Potential Biomarkers for Detecting Acute Ischemic Stroke

  2014influential citation
• Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans

  2013cites this paper
• Stroke Update 2012: Etiology and Mechanism of Stroke

  2012cites this paper
• THE SYSTEM OF IL-6 AS A RISK FACTOR OF URGENT CRITICAL CONDITION DEVELOPMENT IN PATIENTS WITH ESSENTIAL HYPERTENSION

  2012cites this paper